Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been assigned a consensus rating of "Buy" from the six research firms that are currently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $12.13.
BIOX has been the topic of several analyst reports. Lake Street Capital reduced their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating on the stock in a research report on Wednesday, September 11th. Canaccord Genuity Group decreased their price target on Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Roth Mkm dropped their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, September 11th. Finally, Oppenheimer decreased their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating on the stock in a research report on Monday, October 21st.
View Our Latest Stock Analysis on BIOX
Shares of NASDAQ BIOX opened at $6.09 on Friday. The stock has a market capitalization of $382.74 million, a PE ratio of 304.65 and a beta of 0.51. Bioceres Crop Solutions has a fifty-two week low of $5.71 and a fifty-two week high of $14.05. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. The business has a fifty day moving average price of $6.78 and a two-hundred day moving average price of $8.91.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The firm had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. During the same period in the prior year, the company earned ($0.07) EPS. As a group, equities analysts predict that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of BIOX. Stifel Financial Corp boosted its stake in shares of Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after purchasing an additional 10,224 shares in the last quarter. Fourth Sail Capital LP boosted its position in Bioceres Crop Solutions by 61.6% during the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock worth $24,957,000 after buying an additional 1,209,277 shares during the period. Long Focus Capital Management LLC grew its holdings in Bioceres Crop Solutions by 19.9% during the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock worth $3,145,000 after acquiring an additional 46,647 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock valued at $688,000 after acquiring an additional 5,341 shares during the period. Finally, Ping Capital Management Inc. bought a new position in shares of Bioceres Crop Solutions during the second quarter valued at $448,000. Institutional investors own 17.68% of the company's stock.
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.